Pifithrin-α (PFTα): Precision Tools for Dissecting p53-Drive
2026-07-17
Explore how Pifithrin-α, a potent p53 inhibitor, enables advanced dissection of p53-dependent apoptosis and ferroptosis in neurotoxicity models. Gain new insights into experimental design and translational applications for mitigating cell death.
Forsythoside E: From PKM2 Inhibition to Macrophage Metabolic
2026-07-17
Explore the mechanistic depth of Forsythoside E as a pyruvate kinase M2 (PKM2) inhibitor and macrophage M2 polarization inducer. This article reveals new scientific insights beyond protocol optimization, guiding advanced sepsis-induced liver injury research.
Amphotericin B: Protocol Optimization for Fungal Infection R
2026-07-16
Amphotericin B, a potent polyene antifungal antibiotic, is pivotal in experimental modeling of fungal infections and membrane sterol interactions. This article dissects advanced workflows, troubleshooting, and the integration of recent protoplast lysis insights to elevate reproducibility and assay sensitivity.
PTT and CD47 Blockade Synergy Remodels OSCC Immunity
2026-07-16
The referenced study demonstrates that photothermal therapy (PTT) combined with CD47 blockade significantly enhances anti-tumor immunity in oral squamous cell carcinoma (OSCC). By inducing calreticulin exposure and remodeling the tumor extracellular matrix, this approach improves macrophage infiltration and phagocytosis—offering mechanistic insight for next-generation immunotherapeutic strategies.
Tacalcitol Monohydrate: Synthetic Vitamin D3 for Translation
2026-07-15
Tacalcitol monohydrate, a synthetic analog of vitamin D3, empowers researchers with robust, VDR-mediated gene modulation for dermatological and oncology models. Its precise workflow parameters and low calcemic toxicity open new avenues for NGF induction, psoriasis treatment studies, and combinatorial cancer therapies.
Ibrexafungerp Efficacy Against Fluconazole-Resistant Candida
2026-07-15
This study demonstrates that ibrexafungerp (MK 3118) exhibits potent in vitro activity and in vivo efficacy against fluconazole-resistant Candida auris, including when treatment is initiated after infection establishment. The findings highlight ibrexafungerp as a promising oral antifungal agent for tackling multidrug-resistant C. auris infections, with practical implications for antifungal research and preclinical model development.
Prestained Protein Marker: Triple Color Protein Ladder in Ad
2026-07-14
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) empowers researchers with visible, reliable molecular weight standards for complex SDS-PAGE and Western blot workflows. Its triple-color system and EDTA-free compatibility streamline phosphoprotein and fluorescent analyses, sharpening interpretation and troubleshooting for translational research.
Ferrocenyl Novobiocin Derivatives: Enhanced Antiparasitic an
2026-07-14
The referenced study reports the synthesis of novel ferrocenyl and organic novobiocin derivatives and evaluates their biological effects against Plasmodium falciparum and human breast cancer cells. Incorporation of a ferrocene moiety into the aminocoumarin antibiotic scaffold yielded compounds with improved antiparasitic and anticancer properties, highlighting structure-activity relationships relevant to antibacterial resistance and drug development.
HyperScribe™ Poly (A) Tailing Kit: Precision for mRNA Stabil
2026-07-13
This evidence-based guide explores real-world laboratory challenges in mRNA polyadenylation and demonstrates how the HyperScribe™ Poly (A) Tailing Kit (SKU K1053) reliably addresses them. Drawing on peer-reviewed data and practical scenarios, we showcase its role in enhancing mRNA stability and translation efficiency for cell-based assays and gene expression studies.
Applied Use-Cases of Verapamil ((±)-Verapamil) in Hypoxia-Dr
2026-07-13
Verapamil ((±)-Verapamil) is redefining inflammation research beyond its classic cardiovascular applications. With proven efficacy in dissecting the ROS/TXNIP/NLRP3 axis, it enables robust, reproducible workflows for urothelial hypoxia models and multidrug resistance studies.
Myotubularin 2 Regulates Autophagy via SEC23A at ER Exit Sit
2026-07-12
This study uncovers Myotubularin 2 (MTM2) as a phosphatidylinositol 3-phosphate phosphatase that localizes to ER exit sites and interacts with SEC23A, thereby negatively regulating autophagy in Arabidopsis. These findings reveal a new mechanistic link between autophagy and COPII-mediated protein secretion, with broader implications for stress adaptation and endomembrane trafficking research.
HO-1 Modulation Disrupts HBV Replication via ROS in Hepatocy
2026-07-10
A recent study demonstrates that isochlorogenic acid A impairs hepatitis B virus (HBV) replication by upregulating heme oxygenase-1 (HO-1), altering intracellular ROS, and interfering with critical stages of the viral life cycle. These findings highlight the therapeutic potential of targeting HO-1 and redox homeostasis in chronic HBV infection.
Erastin in Neuro-Metabolic Research: Ferroptosis Beyond Onco
2026-07-09
Explore how Erastin, a leading ferroptosis inducer, enables advanced research on oxidative cell death across cancer biology and neuro-metabolic disease. This article uniquely bridges oncology and neuroscience, extracting key assay insights from recent ferroptosis studies.
Angiotensin III: Precision RAAS Modulation for Translational
2026-07-09
Explore the mechanistic and translational value of Angiotensin III (Arg-Val-Tyr-Ile-His-Pro-Phe) as a next-generation cardiovascular and neuroendocrine research peptide. This article delivers actionable insights on leveraging its unique receptor profile, evidence-backed protocol parameters, and cross-domain relevance—including emerging links to viral pathogenesis. Discover how APExBIO’s Angiotensin III (human, mouse) enables reproducible, strategic exploration of RAAS signaling, with practical guidance for researchers at the interface of mechanistic discovery and clinical translation.
Syringin Enhances Sunitinib Efficacy via EGFR/PI3K/Akt Inhib
2026-07-08
The reference study demonstrates that Syringin, a natural product, inhibits renal cell carcinoma (RCC) cell growth and enhances the efficacy of sunitinib by targeting the EGFR/PI3K/Akt signaling pathway. This finding advances current understanding of overcoming sunitinib resistance in RCC and provides a mechanistic framework for integrating Syringin into bioactive compound screening and apoptosis research.
466 records 12/32 page Previous Next First page 上5页 1112131415 下5页 Last page